The clinical pharmacokinetics of Vinorelbine (Navelbine)WARGIN, W. A; LUCAS, V. S.Seminars in oncology. 1994, Vol 21, Num 5, pp 21-27, issn 0093-7754, SUP10Conference Paper

A normal phase HPLC method for the determination of two arylmethylamino-propanediols (AMPAs), crisnatol and 773U82 in plasmaHSIEH, A.-L. Y; BULKOWSKI, D. M; WARGIN, W. A et al.Journal of liquid chromatography. 1991, Vol 14, Num 14, pp 2735-2744, issn 0148-3919Article

Factors associated with nephrotoxicity and clinical outcome in patients receiving amikacinWILLIAMS, P. J; HULL, J. H; SARUBBI, F. A et al.Journal of clinical pharmacology. 1986, Vol 26, Num 2, pp 79-86, issn 0091-2700Article

Pharmacokinetics of oral and transdermal triprolidineMILES, M. V; BALASUBRAMANIAN, R; PITTMAN, A. W et al.Journal of clinical pharmacology. 1990, Vol 30, Num 6, pp 572-575, issn 0091-2700, 4 p.Article

Pharmacokinetics and pharmacodynamics of doxacurium in young and elderly patients during isoflurane anesthesiaDRESNER, D. L; BASTA, S. J; ALI, H. H et al.Anesthesia and analgesia. 1990, Vol 71, Num 5, pp 498-502, issn 0003-2999, 5 p.Article

The pharmacokinetics of 1954U89, 1,3-diamino-7-(1-ethylpropyl)-8-methyl-7H-pyrrolo-(3,2-f)quinazoline, in dogs and rats after intravenous and oral administrationSTUDENBERG, S. D; WOOLLEY, J. L; DEANGELIS, D. V et al.Biopharmaceutics & drug disposition. 1997, Vol 18, Num 5, pp 433-442, issn 0142-2782Article

Importance of the organ-independent elimination of cisatracuriumKISOR, D. F; SCHMITH, V. D; WARGIN, W. A et al.Anesthesia and analgesia. 1996, Vol 83, Num 5, pp 1065-1071, issn 0003-2999Article

The effects of food and divised dosing on the bioavailability of oral vinorelbineROWINSKY, E. K; SOL LUCAS, V; HSIEH, A.-L. Y et al.Cancer chemotherapy and pharmacology. 1996, Vol 39, Num 1-2, pp 9-16, issn 0344-5704Article

Crisnatol mesylate : phase I dose escalation by extending infusion durationPOPLIN, E. A; CHABOT, G. G; TUTTLE, R. L et al.Investigational new drugs. 1991, Vol 9, Num 1, pp 41-47, issn 0167-6997, 7 p.Article

Pharmacokinetics of RheothRx Injection in healthy male volunteersJEWELL, R. C; KHOR, S. P; KISOR, D. F et al.Journal of pharmaceutical sciences. 1997, Vol 86, Num 7, pp 808-812, issn 0022-3549Article

Bidirectional interaction of valproate and lamotrigine in healthy subjectsANDERSON, G. D; YAU, M. K; GIDAL, B. E et al.Clinical pharmacology and therapeutics. 1996, Vol 60, Num 2, pp 145-156, issn 0009-9236Article

Pharmacokinetics and safety of lamotrigine (Lamictal®) in patients with epilepsyRAMSAY, R. E; PELLOCK, J. M; OTTO, V et al.Epilepsy research. 1991, Vol 10, Num 2-3, pp 191-200, issn 0920-1211Article

Antipyrine kinetics following partial blood exchange with fluosol-DA in the ratSHREWSBURY, R. P; WHITE, S. G; POLLACK, G. M et al.Journal of pharmacy and pharmacology. 1986, Vol 38, Num 12, pp 883-887, issn 0022-3573Article

Antipyrine kinetics following partial blood exchange with fluosol-DA in the ratSHREWSBURY, R. P; WHITE, S. G; POLLACK, G. M et al.Journal of pharmacy and pharmacology. 1986, Vol 38, Num 12, pp 883-887, issn 0022-3573Article

Inhibition of theophylline clearance by cimetidine but not ranitidinePOWELL, J. R; ROGERS, J. F; WARGIN, W. A et al.Archives of internal medicine (1960). 1984, Vol 144, Num 3, pp 484-486, issn 0003-9926Article